| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 05/19/2011 | US20110118173 Method of delipidation of hdl using serum opacity factor to prevent, inhibit, and/or reverse atherosclerosis |
| 05/19/2011 | US20110117224 Composition Comprising Bamboo Extract and the Compounds Isolated Therefrom Showing Treating and Preventing Activity for Inflammatory and Blood Circulation Disease |
| 05/19/2011 | US20110117164 Use of Additive Sites to Control Nitric Oxide Release from Nitric Oxide Donors Contained within Polymers |
| 05/19/2011 | US20110117162 Isolated Renal Cells and Uses Thereof |
| 05/19/2011 | US20110117139 Fully synthetic albumin analog |
| 05/19/2011 | US20110117061 Ex Vivo Expansion of Human Hematopoietic Stem Cells |
| 05/19/2011 | US20110117054 Use of ribavirin in blood coagulation disorder |
| 05/19/2011 | US20110117008 Use of avicins to deliver therapeutic and diagnostic agents |
| 05/19/2011 | CA2780763A1 Factor viii b cell epitope variants having reduced immunogenicity |
| 05/19/2011 | CA2780761A1 Factor viii t cell epitope variants having reduced immunogenicity |
| 05/19/2011 | CA2780542A1 Von willebrand factor (vwf)-containing preparations, and methods, kits, and uses related thereto |
| 05/19/2011 | CA2778880A1 Methods of treating or preventing stent thrombosis |
| 05/19/2011 | CA2778316A1 N-2 pyrazolospiroketone acetyl-coa carboxylase inhibitors |
| 05/19/2011 | CA2778175A1 8-azabicyclo[3.2.1]octane-8-carboxamide derivative |
| 05/18/2011 | EP2322631A1 In vivo incorporation of unnatural amino acids |
| 05/18/2011 | EP2322601A1 Method of collecting placental stem cells |
| 05/18/2011 | EP2322513A2 Intermediates |
| 05/18/2011 | EP2322229A2 Remodelling and glycoconjugation of Granulocyte Colony Stimulating Factor (G-CSF) |
| 05/18/2011 | EP2322207A2 Oxygen-transferring blood substitute and a pharmaceutical composition (variants) |
| 05/18/2011 | EP2322155A1 Use of HIF alpha stabilizers for enhancing erythropoiesis |
| 05/18/2011 | EP2322154A2 Methods for detecting and clearing cross beta structure comprising proteins with crossbeta structure binding compounds. |
| 05/18/2011 | EP2322153A1 Use of HIF Alpha stabilizers for enhancing erythropoiesis |
| 05/18/2011 | EP2321301A1 New heterocyclic carboxamides for use as thrombin inhibitors |
| 05/18/2011 | EP1910420B1 Human inhibitory anti-factor viii antibodies binding to the a2 domain |
| 05/18/2011 | CN1919210B System for the liberation of an active principle and its use |
| 05/18/2011 | CN1665554B Compounds and method for preparing surfaces in a haemocompatible manner |
| 05/18/2011 | CN102066938A Method for determination of edema associated with liver disease |
| 05/18/2011 | CN102066379A Imidazo [2,1-b] quinazolin-2-one derivatives and their use as platelet anti-aggregative agents |
| 05/18/2011 | CN102066341A Substituted quinazolines |
| 05/18/2011 | CN102066337A 5-hydroxypyrimidine-4-carboxamide compound |
| 05/18/2011 | CN102066326A Pyridone compound |
| 05/18/2011 | CN102065899A Formulations of PEG-functionalised serine proteases with high concentrations of an aromatic preservative |
| 05/18/2011 | CN102060934A Enzymatic extraction method for auricularia auricula polysaccharides |
| 05/18/2011 | CN102060932A Process method for synchronously producing pueraria starch and pueraria flavonoid |
| 05/18/2011 | CN102060921A High-stability VPAC2 type receptor specific activator MHDBAY, preparation method and application thereof |
| 05/18/2011 | CN102060908A Novel synthetic antithrombotic polypeptide, and preparation method and application thereof |
| 05/18/2011 | CN102060842A 3-(substituted xylylenimine-2-yl)-2,6-piperidine diketone polymorph and medical composition |
| 05/18/2011 | CN102060824A Method for preparing coumarin |
| 05/18/2011 | CN102060808A Cinepazide acid addition salt and preparation method thereof |
| 05/18/2011 | CN102060806A Cytokine inhibitors |
| 05/18/2011 | CN102060787A Tetramethylpyrazine ferulate crystals for suppressing platelet aggregation and thrombosis and preparation method thereof |
| 05/18/2011 | CN102058898A Powder with antibacterial and haemostatic effects and preparation method and applications thereof |
| 05/18/2011 | CN102058889A Dispersible tablet containing anticoagulants and application thereof |
| 05/18/2011 | CN102058888A Pharmaceutical composition for treatment of abnormal energy metabolism and application thereof |
| 05/18/2011 | CN102058886A Medical powder inhalation and application thereof |
| 05/18/2011 | CN102058863A Chinese medicinal composition for eliminating body edema |
| 05/18/2011 | CN102058836A Medicament composition with effects of resisting thrombus, reducing blood pressure and treating leukemia |
| 05/18/2011 | CN102058805A Oral medicine for preventing and treating leukocytopenia caused by chemotherapy |
| 05/18/2011 | CN102058797A Chinese medicine for treating cerebral hemorrhage and preparation method thereof |
| 05/18/2011 | CN102058753A Medicament for replenishing qi to invigorate spleen and preparation method |
| 05/18/2011 | CN102058736A Medicament for preventing and treating blood group incompatible hemolytic disease during pregnancy and preparation method thereof |
| 05/18/2011 | CN102058714A Medicinal composition for treating hemophilia |
| 05/18/2011 | CN102058668A Traditional Chinese medicinal preparation for treating primary thrombocytopenia |
| 05/18/2011 | CN102058663A Clathrate compound formed by Salvia miltiorrhiza Bunge and cyclodextrin and application thereof |
| 05/18/2011 | CN102058654A Astragalus membranaceus dispersible tablet and preparation method thereof |
| 05/18/2011 | CN102058631A Seabuckthorn leaf extract preparation and preparation method thereof |
| 05/18/2011 | CN102058620A Fistula affused liquid medicine for anal fistula |
| 05/18/2011 | CN102058596A Method for preparing chelerythrine medicament and application thereof in prevention and treatment of bacterial diseases of aquatic animals |
| 05/18/2011 | CN102058550A Clopidogrel bisulfate tablet and preparation method thereof |
| 05/18/2011 | CN102058528A Daidzein micelles and preparation method thereof |
| 05/18/2011 | CN101810705B Content determination method of sanguisorbin I |
| 05/18/2011 | CN101745082B Traditional Chinese medicinal composition for treating haemorrhage after medical abortion and preparation method thereof |
| 05/18/2011 | CN101670017B Medicine combination for tonifying blood |
| 05/18/2011 | CN101632669B Method of using diketopiperazines and composition containing them |
| 05/18/2011 | CN101612177B Finger-print building method of radix cyathulae medicinal material |
| 05/18/2011 | CN101549010B A preparing method and application of malaytea scurfpea fruit total glycosides extract |
| 05/18/2011 | CN101143004B Moxa leaf rice paste and its making method |
| 05/18/2011 | CN101129972B Traditional Chinese medicine composition, preparation method and use of the same |
| 05/17/2011 | US7943595 Polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative |
| 05/17/2011 | US7943571 Modified proteins, designer toxins, and methods of making thereof |
| 05/17/2011 | CA2484374C Medical products comprising a haemocompatible coating, production and use thereof |
| 05/17/2011 | CA2474242C Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light |
| 05/17/2011 | CA2451521C Use of poly-glu, tyr for neuroprotective therapy |
| 05/17/2011 | CA2413945C Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| 05/17/2011 | CA2411642C Use of ingenanes for the activation of latent virus infection |
| 05/17/2011 | CA2401385C Protein matrix materials, devices and methods of making and using thereof |
| 05/17/2011 | CA2391923C Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 05/12/2011 | WO2011056978A2 S isomers of alpha-methyl hydrocinnamic acid for the treatment of blood disorders |
| 05/12/2011 | WO2011055561A1 Protein crosslinking inhibitor and use thereof |
| 05/12/2011 | WO2011055550A1 Therapeutic agent for autoimmune diseases or allergy, and method for screening for the therapeutic agent |
| 05/12/2011 | WO2011054174A1 Depolymerized fucosylated glycosaminoglycan and preparation method thereof |
| 05/12/2011 | WO2011005527A3 Ketoreductase-mediated stereoselective route to alpha chloroalcohols |
| 05/12/2011 | WO2010148012A3 Hemostatic material and delivery device |
| 05/12/2011 | WO2010144339A3 A thrombin receptor antagonist and clopidogrel fixed dose tablet |
| 05/12/2011 | US20110112193 Bis-aryl compounds for use as medicaments |
| 05/12/2011 | US20110112140 Inhibitor of plasminogen activator inhibitor-1 |
| 05/12/2011 | US20110112134 Tricyclic Antagonists of Prostaglandin D2 Receptors |
| 05/12/2011 | US20110112109 Triazolone derivatives |
| 05/12/2011 | US20110112103 5-hydroxypyrimidine-4-carboxamide compound |
| 05/12/2011 | US20110112090 Depsipeptides and Their Therapeutic Use |
| 05/12/2011 | US20110112084 Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 05/12/2011 | US20110112083 Fxa inhibitors with cyclic amidoxime or cyclic amidrazone as p4 subunit, processes for their preparations, and pharmaceutical compositions and derivatives thereof |
| 05/12/2011 | US20110112075 Chlorothiophene-amides as inhibitors of coagulation factors xa and thrombin |
| 05/12/2011 | US20110112074 Chlorothiophene-isoxazoles as inhibitors of coagulation factors xa and thrombin |
| 05/12/2011 | US20110112067 Inhibitors of the Human Aldosterone Sythase CYP11B2 |
| 05/12/2011 | US20110112058 Novel modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer |
| 05/12/2011 | US20110112050 Separation of polysaccharides by charge density gradient |
| 05/12/2011 | US20110112030 Methods of treating or preventing stent thrombosis |
| 05/12/2011 | US20110112028 Factor viii polymer conjugates |
| 05/12/2011 | US20110112027 Factor viii polymer conjugates |